• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: B. BRAUN SURGICAL, S.A. OPTILENE 4/0 (1,5) 75CM 2XDR13 CV RCP; CARDIAC SUTURE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

B. BRAUN SURGICAL, S.A. OPTILENE 4/0 (1,5) 75CM 2XDR13 CV RCP; CARDIAC SUTURE Back to Search Results
Model Number C3095908
Device Problem Material Twisted/Bent (2981)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Manufacturer Narrative
If additional information becomes available a follow up report will be submitted.
 
Event Description
It was reported that there was an issue with optilene suture.The client reported that the tip of the needle bends when it passes through tissue and vein.The type of surgery was prosthesis removal with subsequent implantation of a vein interposition.There was no patient harm and the outcome was good.No additional information has been provided.
 
Manufacturer Narrative
Analysis and results: there are no previous complaints of this code batch of which we manufactured 252 units.There are 36 units in stock in b.Braun surgical's warehouse.We have received an open pack with a used needle.The needle has been visually analyzed and the tip of the needle is bent due to a needle holder.There are marks of it in the bending area.Bending strength test has been performed to the used needle and the result is 5.99 nxcm in minimum, fulfilling the specifications of the needle: 4.2 nxcm in minimum.Reviewed the batch manufacturing records of the needle batch, the results of the needle bending strength tests were 5.81 nxcm in minimum, fulfilling the specifications (4.2 nxcm in minimum).We conclude that the needle bending in the tip area is caused by a wrong handling of the needle, not according to the instructions for use of the product.(care should be taken to avoid damaging the needle when using the suture material.Always grasp the needle in a section 1/3 to 1/2 of the distance from the fibre attachment end to the needle point, never at the end where the fibre is attached or the needle point.) final conclusion: although the results of the samples received fulfil the specifications of european pharmacopoeia/ b.Braun surgical specifications, we take note of this incidence in order to assess if new or additional actions are needed.The case is considered not confirmed by evidence of the samples received.Actions on product distributed of this reference/batch: based on the conclusion derived from investigation, it is not required to make actions in distributed product.Corrective/preventive actions: according to our internal procedures, there is no need to establish corrective or preventive actions.Nevertheless, this complaint is recorded for trending analysis to assess if actions are needed in the future.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTILENE 4/0 (1,5) 75CM 2XDR13 CV RCP
Type of Device
CARDIAC SUTURE
Manufacturer (Section D)
B. BRAUN SURGICAL, S.A.
carretera de terrassa 121
rubí, barcelona 08191
SP  08191
MDR Report Key10940535
MDR Text Key219340197
Report Number3003639970-2020-00451
Device Sequence Number1
Product Code GAW
Combination Product (y/n)Y
PMA/PMN Number
K133890
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 01/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberC3095908
Device Catalogue NumberC3095908
Device Lot Number119483
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/17/2020
Initial Date Manufacturer Received 11/19/2020
Initial Date FDA Received12/03/2020
Supplement Dates Manufacturer Received01/04/2021
Supplement Dates FDA Received01/07/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-